{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:50:54Z","timestamp":1788385854475,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ejpb.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T10:27:08Z","timestamp":1592735228000},"page":"116-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids"],"prefix":"10.1016","volume":"154","author":[{"given":"Laura J.","family":"Henze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas J.","family":"Koehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vertzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil D.","family":"Whitfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan T.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.06.009_b0005","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2016.12.004","article-title":"Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies","volume":"99","author":"Grignard","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0010","series-title":"The Impact of Food Bioactives on Health: in vitro and ex vivo models","first-page":"37","article-title":"The TNO Gastro-Intestinal Model (TIM)","author":"Minekus","year":"2015"},{"key":"10.1016\/j.ejpb.2020.06.009_b0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1208\/s12248-018-0231-8","article-title":"The BioGIT System: a Valuable In Vitro Tool to Assess the Impact of Dose and Formulation on Early Exposure to Low Solubility Drugs After Oral Administration","volume":"20","author":"Kourentas","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2020.06.009_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejps.2015.11.012","article-title":"An in vitro biorelevant gastrointestinal transfer (BioGIT) system for forecasting concentrations in the fasted upper small intestine: design, implementation, and evaluation","volume":"82","author":"Kourentas","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0025","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0030","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ejpb.2015.05.015","article-title":"Advances in the design of fasted state simulating intestinal fluids: FaSSIF-V3","volume":"94","author":"Fuchs","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2015.03.009","article-title":"In-vitro simulation of luminal conditions for evaluation of performance of oral drug products: choosing the appropriate test media","volume":"93","author":"Markopoulos","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.2042-7158.2012.01474.x","article-title":"Biorelevant in-vitro performance testing of orally administered dosage forms","volume":"64","author":"Reppas","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.06.009_b0050","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2013.01.010","article-title":"Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state","volume":"84","author":"Arndt","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.18433\/J37606","article-title":"Prediction of oral absorption of low-solubility drugs by using rat simulated gastrointestinal fluids: the importance of regional differences in membrane permeability and solubility","volume":"17","author":"Tanaka","year":"2014","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0060","article-title":"Toward the establishment of a standardized pre-clinical porcine model to predict food effects \u2013 case studies on fenofibrate and paracetamol","volume":"1","author":"Henze","year":"2019","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.ejpb.2020.06.009_b0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","article-title":"A simple method for the isolation and purification of total lipides from animal tissues","volume":"226","author":"Folch","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2020.06.009_b0070","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s11095-006-0207-8","article-title":"Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0075","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper gastrointestinal (GI) PH in young, healthy-men and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1023\/A:1018939204809","article-title":"Variability in gastric pH and delayed gastric emptying in Yucatan miniature pigs","volume":"11","author":"Oberle","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0939-6411(99)00070-3","article-title":"Gastric pH profiles of beagle dogs and their use as an alternative to human testing","volume":"49","author":"Akimoto","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.ejpb.2013.05.007","article-title":"Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities","volume":"85","author":"Pedersen","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1012107801889","article-title":"Characterization of fluids from the stomach and proximal jejunum in men and women","volume":"14","author":"Lindahl","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0105","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.10.015","article-title":"Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs","volume":"57","author":"Bergstrom","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0110","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jps.24603","article-title":"Characterization of human duodenal fluids in fasted and fed state conditions","volume":"105","author":"Riethorst","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0115","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1002\/jps.24183","article-title":"Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data","volume":"103","author":"Fuchs","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0120","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijpharm.2013.04.003","article-title":"Bile salts and their importance for drug absorption","volume":"453","author":"Holm","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ijpharm.2010.12.007","article-title":"Equilibrium drug solubility measurements in 96-well plates reveal similar drug solubilities in phosphate buffer pH 6.8 and human intestinal fluid","volume":"405","author":"Heikkila","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.addr.2019.06.010","article-title":"In vitro digestion models to evaluate lipid based drug delivery systems; present status and current trends","volume":"142","author":"Berthelsen","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.06.009_b0135","article-title":"The pig as a preclinical model for predicting oral bioavailability and in vivo performance of pharmaceutical oral dosage forms: a PEARRL review","author":"Henze","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.06.009_b0140","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1021\/acs.molpharmaceut.6b01155","article-title":"Impact of gut microbiota-mediated bile acid metabolism on the solubilization capacity of bile salt micelles and drug solubility","volume":"14","author":"Enright","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0022-2275(20)41684-0","article-title":"Analysis of metabolic profiles of bile-acids in urine using a lipophilic anion-exchanger and computerized gas-liquid chromatography mass spectrometry","volume":"18","author":"Alme","year":"1977","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0150","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0168-8278(96)80268-6","article-title":"Stimulation of bile acid 6 alpha-hydroxylation by rifampin","volume":"24","author":"Wietholtz","year":"1996","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejpb.2020.06.009_b0155","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/095530099140663","article-title":"Modified bile acid profiles in mixed neutron and gamma-irradiated pigs","volume":"75","author":"Scanff","year":"1999","journal-title":"Int. J. Radiat Biol."},{"key":"10.1016\/j.ejpb.2020.06.009_b0160","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0305-0491(86)90295-6","article-title":"Relationships between bile-salts hydrophilicity and phospholipid-composition in bile of various animal species","volume":"83","author":"Alvaro","year":"1986","journal-title":"Comp. Biochem. Phys. B"},{"key":"10.1016\/j.ejpb.2020.06.009_b0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejpb.2009.05.009","article-title":"Prediction of food effects on the absorption of celecoxib based on biorelevant dissolution testing coupled with physiologically based pharmacokinetic modeling","volume":"73","author":"Shono","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0170","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.addr.2007.05.009","article-title":"Estimating drug solubility in the gastrointestinal tract","volume":"59","author":"Dressman","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2020.06.009_b0175","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/mp100144v","article-title":"Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids","volume":"7","author":"Soderlind","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0180","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-005-8192-x","article-title":"The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids","volume":"22","author":"Persson","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/A:1007576713216","article-title":"A comparison of the solubility of danazol in human and simulated gastrointestinal fluids","volume":"17","author":"Pedersen","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejps.2009.10.005","article-title":"Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption","volume":"39","author":"Annaert","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ejps.2011.04.016","article-title":"Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids","volume":"43","author":"Clarysse","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0200","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s11095-009-9857-7","article-title":"Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs","volume":"26","author":"Clarysse","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2020.06.009_b0205","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1021\/mp100377m","article-title":"Excipient-mediated supersaturation stabilization in human intestinal fluids","volume":"8","author":"Bevernage","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0210","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejps.2013.08.027","article-title":"A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption","volume":"57","author":"Augustijns","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.06.009_b0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.043","article-title":"In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation","volume":"250","author":"McCarthy","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.06.009_b0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2015.07.014","article-title":"Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments","volume":"96","author":"O'Shea","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0225","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2013.10.016","article-title":"Comparison of in vitro tests at various levels of complexity for the prediction of in vivo performance of lipid-based formulations: Case studies with fenofibrate","volume":"86","author":"Griffin","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2020.06.009_b0230","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1208\/s12249-016-0611-2","article-title":"Comparing dog and human intestinal fluids: implications on solubility and biopharmaceutical risk assessment","volume":"18","author":"Walsh","year":"2017","journal-title":"AAPS PharmSciTech"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120301776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:38:25Z","timestamp":1760546305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120301776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":46,"alternative-id":["S0939641120301776"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.009","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and evaluation of a biorelevant medium simulating porcine gastrointestinal fluids","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}